SCHEDULE 13G/A: BlackRock Amends Stake in Phibro Animal Health, Disclosing 15.7% Beneficial Ownership

BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 15.7% beneficial ownership stake in Phibro Animal Health Corp's Class A Stock as of March 31, 2025.

Summary

• BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G regarding its beneficial ownership in Phibro Animal Health Corp.
• As of March 31, 2025, BlackRock, Inc. beneficially owns 3,195,124 shares of Phibro Animal Health Corp's Class A Stock.
• This ownership represents 15.7% of the Class A Stock outstanding.
• BlackRock holds sole voting power over 3,159,906 shares and sole dispositive power over 3,195,124 shares.
• No shared voting or dispositive power is reported.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• One specific BlackRock entity, iShares Core S&P Small-Cap ETF, is noted to beneficially own 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently suggest a positive or negative sentiment regarding the issuer's performance or prospects. It is a routine regulatory filing.

Future Outlook

This document is a beneficial ownership report and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.

Industry Context

This filing is a routine disclosure by a major institutional asset manager, BlackRock, indicating its passive investment stake in Phibro Animal Health Corp. Such disclosures are common for large investment firms that manage significant portfolios across various public companies. The 15.7% stake positions BlackRock as a substantial institutional shareholder in Phibro.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and liquidity.
• Management: Awareness of a large, passive institutional holder, though the filing explicitly states no intent to influence control.

Key Dates

Keywords

BlackRock, Phibro Animal Health Corp, Schedule 13G, Beneficial Ownership, Class A Stock, Institutional Investor, SEC Filing, Equity Stake